Pilot study of the reducing effect on amyloidosis in vivo by three FDA pre-approved drugs via the Alzheimer's APP 5' untranslated region. Journal Articles Refereed uri icon

Overview

Authors

Published in

  • Current Alzheimer Research

Time

Date/time value

  • 2005

Identity

Digital Object Identifier (DOI)

  • 10.2174/1567205053585855

Additional Document Info

Parent Title

  • Curr Alzheimer Res

Volume

  • 2

Issue

  • 2

Publisher

  • Bentham Science Publishers